Literature DB >> 8950008

Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity.

I Weiner1, G Gal, J N Rawlins, J Feldon.   

Abstract

Latent inhibition (LI) consists of retardation in conditioning to a stimulus as a consequence of its prior non-reinforced pre-exposure. In view of findings that LI is disrupted in acute schizophrenic patients and evidence from animal experiments pointing to the involvement of the mesolimbic dopamine (DA) system in this phenomenon, the present study investigated the effects of electrolytic lesions to the shell and core subterritories of the nucleus accumbens on LI in rats (Expt. 1). LI was indexed by the amount of suppression of drinking in the presence of a tone that was either pre-exposed or not prior to its pairing with reinforcement (a foot shock). Expt.2 tested the effects of the DA antagonist, haloperidol, on LI in shell- and core-lesioned animals. Expt. 3 tested the effects of shell and core lesions on spontaneous and amphetamine-induced locomotion. In Expt. 1, LI, i.e., lower suppression of drinking in the pre-exposed as compared to the non-pre-exposed animals, was obtained in the sham-operated condition. Core and shell lesions produced distinct effects on LI. Animals with core lesions developed LI, but exhibited an overall lower suppression of drinking in comparison to the sham-operated animals. In contrast, shell lesions led to a disappearance of LI. Expt. 2 replicated the differential effects of shell and core lesions on LI, although in this experiment, core lesion did not attenuate suppression of drinking. Haloperidol prevented shell-induced abolition of LI. In Expt. 3, shell- but not core-lesioned animals were more active than sham controls following amphetamine administration. These results provide evidence for functional differences between the shell and core subregions, as well as for the involvement of the mesolimbic DA system in LI.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950008     DOI: 10.1016/s0166-4328(96)00051-4

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  30 in total

1.  Involvement of D1 and D2 dopamine receptor in the retrieval processes in latent inhibition.

Authors:  E Diaz; J Medellín; N Sánchez; J P Vargas; J C López
Journal:  Psychopharmacology (Berl)       Date:  2015-09-08       Impact factor: 4.530

Review 2.  Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.

Authors:  Antonio Alcaro; Robert Huber; Jaak Panksepp
Journal:  Brain Res Rev       Date:  2007-08-21

3.  Dissociable roles for the nucleus accumbens core and shell in regulating set shifting.

Authors:  Stan B Floresco; Sarvin Ghods-Sharifi; Claudia Vexelman; Orsolya Magyar
Journal:  J Neurosci       Date:  2006-03-01       Impact factor: 6.167

4.  Nucleus accumbens lesions modulate the effects of methylphenidate.

Authors:  Adam Podet; Min J Lee; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2010-05-12       Impact factor: 4.077

5.  Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats.

Authors:  Christopher M Lack; Sara R Jones; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

6.  Distinct effects of enriched environment on dopamine clearance in nucleus accumbens shell and core following systemic nicotine administration.

Authors:  Jun Zhu; Michael T Bardo; Linda P Dwoskin
Journal:  Synapse       Date:  2012-11-08       Impact factor: 2.562

Review 7.  Consideration of species differences in developing novel molecules as cognition enhancers.

Authors:  Jared W Young; J David Jentsch; Timothy J Bussey; Tanya L Wallace; Daniel M Hutcheson
Journal:  Neurosci Biobehav Rev       Date:  2012-10-12       Impact factor: 8.989

Review 8.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

9.  Procognitive and antipsychotic efficacy of glycine transport 1 inhibitors (GlyT1) in acute and neurodevelopmental models of schizophrenia: latent inhibition studies in the rat.

Authors:  Mark D Black; Geoffrey B Varty; Michal Arad; Segev Barak; Amaya De Levie; Denis Boulay; Philippe Pichat; Guy Griebel; Ina Weiner
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

10.  Contrasting effects of selective lesions of nucleus accumbens core or shell on inhibitory control and amphetamine-induced impulsive behaviour.

Authors:  E R Murphy; E S J Robinson; D E H Theobald; J W Dalley; T W Robbins
Journal:  Eur J Neurosci       Date:  2008-07       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.